Market Overview:
The global barbiturate anticonvulsant drugs market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in this market can be attributed to the increasing incidence of seizures and epilepsy, rising geriatric population, and growing demand for combination drugs. Based on type, the global barbiturate anticonvulsant drugs market is segmented into ultra-short acting barbiturate anticonvulsant drugs, short-acting barbiturate anticonvulsant drugs, long-acting barbiturate anticonvulsant drugs and combination drugs. The short-acting barbiturate anticonvulsants segment is expected to register the highest CAGR during the forecast period owing to its high usage in hospitals and clinics across all regions. Based on application, the global Barbituate Anticonsultants Drugs Market is segmented into hospitals and clinics. Hospitals are anticipated to account for a larger share of this market during the forecast period as compared to clinics due to an increase in number of patients suffering from seizures or epilepsy across all regions.
Product Definition:
Barbiturate Anticonvulsant Drugs are a type of medication that is used to help control seizures. They work by slowing down the activity of the brain.
Ultra-Short Acting Barbiturate Anticonvulsant Drugs:
Ultra-Short Acting Barbiturate Anticonvulsant Drugs are a class of barbiturates that have an onset of action within 15 minutes and peak effect usually lasting for 2 to 3 hours. The drug is used as the first line treatment for seizures associated with status epilepticus and also in patients who are at risk of developing tolerance to benzodiazepines.
Short-Acting Barbiturate Anticonvulsant Drugs:
A short-acting barbiturate anticonvulsant is a type of anticonvulsant drug. It works by decreasing the frequency of seizures. Short-acting barbiturate anticonvulsants are used in the treatment of partial onset and primary generalized epilepsy, as well as in some cases of generalized tonic–clonic seizures.
Application Insights:
Based on the application, the global barbiturate anticonvulsant drugs market is segmented into hospitals and clinics. Hospitals held the largest share of over 70.0% in 2017 owing to a high prevalence of epilepsy and awareness about availability of treatment options in case of emergency situations at hospitals. Barbiturates are used as first line therapy for partial seizures with or without secondary generalization (benign) epileptic seizures if there are no other contraindications related to their use such as pregnancy, lactation period, cardiovascular diseases etc.
Regional Analysis:
North America dominated the global barbiturate anticonvulsant drugs market in 2017. The high prevalence of epilepsy and its increasing incidence due to various factors are responsible for the growth of this regional market. According to a study published in Epilepsy & Behavior, approximately 2 million people in U.S.
Growth Factors:
- Increasing prevalence of epilepsy and other seizure disorders
- Growing demand for barbiturate anticonvulsant drugs in developing countries
- Rising awareness about the benefits of barbiturate anticonvulsant drugs
- Technological advancements in the field of barbiturate anticonvulsant drugs development and manufacturing
- Availability of generic versions of branded barbiturate anticonvulsant drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Barbiturate Anticonvulsant Drugs Market Research Report
By Type
Ultra-Short Acting Barbiturate Anticonvulsant Drugs, Short-Acting Barbiturate Anticonvulsant Drugs, Long-Acting Barbiturate Anticonvulsant Drugs, Combination Drugs
By Application
Hospitals, Clinics
By Companies
GlaxoSmithKline plc, Astellas Pharma Inc, Bausch Health Companies Inc., Teva Pharmaceutical Company, Pfizer, Merck, Eli Lilly, Mylan, Sanofi, Sumitomo Dainippon Pharma, Oak Pharmaceuticals, Meda Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Barbiturate Anticonvulsant Drugs Market Report Segments:
The global Barbiturate Anticonvulsant Drugs market is segmented on the basis of:
Types
Ultra-Short Acting Barbiturate Anticonvulsant Drugs, Short-Acting Barbiturate Anticonvulsant Drugs, Long-Acting Barbiturate Anticonvulsant Drugs, Combination Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline plc
- Astellas Pharma Inc
- Bausch Health Companies Inc.
- Teva Pharmaceutical Company
- Pfizer
- Merck
- Eli Lilly
- Mylan
- Sanofi
- Sumitomo Dainippon Pharma
- Oak Pharmaceuticals
- Meda Pharmaceuticals
Highlights of The Barbiturate Anticonvulsant Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ultra-Short Acting Barbiturate Anticonvulsant Drugs
- Short-Acting Barbiturate Anticonvulsant Drugs
- Long-Acting Barbiturate Anticonvulsant Drugs
- Combination Drugs
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Barbiturate Anticonvulsant Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Barbiturate anticonvulsant drugs are medications that work by reducing the activity of nerve cells in the brain. This can help to prevent seizures.
Some of the major players in the barbiturate anticonvulsant drugs market are GlaxoSmithKline plc, Astellas Pharma Inc, Bausch Health Companies Inc., Teva Pharmaceutical Company, Pfizer, Merck, Eli Lilly, Mylan, Sanofi, Sumitomo Dainippon Pharma, Oak Pharmaceuticals, Meda Pharmaceuticals.
The barbiturate anticonvulsant drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Barbiturate Anticonvulsant Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Barbiturate Anticonvulsant Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Barbiturate Anticonvulsant Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Barbiturate Anticonvulsant Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Barbiturate Anticonvulsant Drugs Market Size & Forecast, 2018-2028
4.5.1 Barbiturate Anticonvulsant Drugs Market Size and Y-o-Y Growth
4.5.2 Barbiturate Anticonvulsant Drugs Market Absolute $ Opportunity
Chapter 5 Global Barbiturate Anticonvulsant Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Barbiturate Anticonvulsant Drugs Market Size Forecast by Type
5.2.1 Ultra-Short Acting Barbiturate Anticonvulsant Drugs
5.2.2 Short-Acting Barbiturate Anticonvulsant Drugs
5.2.3 Long-Acting Barbiturate Anticonvulsant Drugs
5.2.4 Combination Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Barbiturate Anticonvulsant Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Barbiturate Anticonvulsant Drugs Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Barbiturate Anticonvulsant Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Barbiturate Anticonvulsant Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Barbiturate Anticonvulsant Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Barbiturate Anticonvulsant Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Barbiturate Anticonvulsant Drugs Market Size Forecast by Type
9.6.1 Ultra-Short Acting Barbiturate Anticonvulsant Drugs
9.6.2 Short-Acting Barbiturate Anticonvulsant Drugs
9.6.3 Long-Acting Barbiturate Anticonvulsant Drugs
9.6.4 Combination Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Barbiturate Anticonvulsant Drugs Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Barbiturate Anticonvulsant Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Barbiturate Anticonvulsant Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Barbiturate Anticonvulsant Drugs Market Size Forecast by Type
10.6.1 Ultra-Short Acting Barbiturate Anticonvulsant Drugs
10.6.2 Short-Acting Barbiturate Anticonvulsant Drugs
10.6.3 Long-Acting Barbiturate Anticonvulsant Drugs
10.6.4 Combination Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Barbiturate Anticonvulsant Drugs Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Barbiturate Anticonvulsant Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Barbiturate Anticonvulsant Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Barbiturate Anticonvulsant Drugs Market Size Forecast by Type
11.6.1 Ultra-Short Acting Barbiturate Anticonvulsant Drugs
11.6.2 Short-Acting Barbiturate Anticonvulsant Drugs
11.6.3 Long-Acting Barbiturate Anticonvulsant Drugs
11.6.4 Combination Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Barbiturate Anticonvulsant Drugs Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Barbiturate Anticonvulsant Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Barbiturate Anticonvulsant Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Barbiturate Anticonvulsant Drugs Market Size Forecast by Type
12.6.1 Ultra-Short Acting Barbiturate Anticonvulsant Drugs
12.6.2 Short-Acting Barbiturate Anticonvulsant Drugs
12.6.3 Long-Acting Barbiturate Anticonvulsant Drugs
12.6.4 Combination Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Barbiturate Anticonvulsant Drugs Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Barbiturate Anticonvulsant Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Barbiturate Anticonvulsant Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Barbiturate Anticonvulsant Drugs Market Size Forecast by Type
13.6.1 Ultra-Short Acting Barbiturate Anticonvulsant Drugs
13.6.2 Short-Acting Barbiturate Anticonvulsant Drugs
13.6.3 Long-Acting Barbiturate Anticonvulsant Drugs
13.6.4 Combination Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Barbiturate Anticonvulsant Drugs Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Barbiturate Anticonvulsant Drugs Market: Competitive Dashboard
14.2 Global Barbiturate Anticonvulsant Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline plc
14.3.2 Astellas Pharma Inc
14.3.3 Bausch Health Companies Inc.
14.3.4 Teva Pharmaceutical Company
14.3.5 Pfizer
14.3.6 Merck
14.3.7 Eli Lilly
14.3.8 Mylan
14.3.9 Sanofi
14.3.10 Sumitomo Dainippon Pharma
14.3.11 Oak Pharmaceuticals
14.3.12 Meda Pharmaceuticals
